Leaky Catecholamine Stores: Undue Waste or a Stress Response Coping Mechanism?
- 1 June 2004
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1018 (1) , 224-230
Abstract
Abstract: Turnover of catecholamines, representing the constant loss and replenishment of neurotransmitter by synthesis, is usually considered to be driven exclusively by catecholamine release. This is incorrect. An important contribution of intraneuronal metabolism of norepinephrine to turnover, and dependence of this on leakage of norepinephrine from vesicular stores, was originally proposed by Kopin in 1964. Several years later, Maas and colleagues concluded that at least 75% of norepinephrine turnover is due to intraneuronal metabolism without prior release at sympathetic nerve endings. More recently it was shown in the resting human heart that about 12% of norepinephrine turnover is due to extraneuronal uptake and metabolism or loss of the transmitter to the circulation, 15% is due to intraneuronal metabolism after reuptake, and 73% is due to intraneuronal metabolism of norepinephrine leaking from storage vesicles. Thus, contrary to usual depictions, vesicular stores of catecholamines do not exist in a static state simply waiting for exocytotic release. Rather, these stores exist in a highly dynamic equilibrium with the surrounding cytoplasm, with passive outward leakage of amines counterbalanced by inward active transport under the control of vesicular monoamine transporters. The large contribution of leakage to catecholamine turnover may seem inconsistent with cellular economy. In fact, this contribution provides an important mechanism for “gearing down” the requirement for increases in catecholamine synthesis to match increases in catecholamine release, and thereby provides sympathetic nerves with a capacity for a more extended range of sustainable release rates in response to stress than would otherwise be possible.Keywords
This publication has 10 references indexed in Scilit:
- Determinants of cardiac tyrosine hydroxylase activity during exercise-induced sympathetic activation in humansAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1998
- Cardiac Sympathetic Nerve Function in Congestive Heart FailureCirculation, 1996
- Effluxes of 3,4‐Dihydroxyphenylalanine, 3,4‐Dihydroxyphenylglycol, and Norepinephrine from Four Blood Vessels During Basal Conditions and During Nerve StimulationJournal of Neurochemistry, 1995
- Increased cardiac production of dihydroxyphenylalanine (DOPA) during sympathetic stimulation in anaesthetized dogsNeurochemistry International, 1992
- Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine.Circulation, 1992
- Neuronal reuptake of norepinephrine and production of dihydroxyphenylglycol by cardiac sympathetic nerves in the anesthetized dog.Circulation, 1991
- The Dynamics of Adrenergic Nerve Endings1989
- Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.Journal of Clinical Investigation, 1988
- Preferential metabolism of (—)-3H-norepinephrine through the deaminated glycol in the rat vas deferensBiochemical Pharmacology, 1973
- Tyrosine HydroxylaseJournal of Biological Chemistry, 1964